Your browser doesn't support javascript.
loading
Emerging therapeutics in the management of connective tissue disease. Part I. Lupus erythematosus and Sjögren syndrome.
Skudalski, Lauren; Shahriari, Neda; Torre, Kristin; Santiago, Sueheidi; Bibb, Lorin; Kodomudi, Vijay; Grant-Kels, Jane M; Lu, Jun.
Afiliación
  • Skudalski L; Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania.
  • Shahriari N; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Torre K; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Santiago S; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Bibb L; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Kodomudi V; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Grant-Kels JM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Lu J; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut. Electronic address: jlu@uchc.edu.
J Am Acad Dermatol ; 87(1): 1-18, 2022 07.
Article en En | MEDLINE | ID: mdl-35202775

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Síndrome de Sjögren / Enfermedades del Tejido Conjuntivo / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Síndrome de Sjögren / Enfermedades del Tejido Conjuntivo / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2022 Tipo del documento: Article